Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people.

https://ift.tt/2QHCnfd support@endlesssupplies.biz (Endless Supplies .Biz) September 19, 2018 at 04:51AM
No comments:
Post a Comment